Develops innovative medicines targeting KCC2 to treat neurological disorders like epilepsy, pain, and other CNS conditions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
AXONIS Therapeutics is a biotechnology company focused on developing first- and best-in-class medicines that target KCC2, a key mediator of inhibition in the brain, to treat neurological disorders. The company leverages its proprietary KCC2 discovery engine to create therapies for conditions such as epilepsy, pain, and other central nervous system pathologies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
AXONIS Therapeutics Management Team
Investors
Cormorant Asset Management
Lumira Ventures
MRL Ventures Fund (MRLV)
Perceptive Advisors
Sofinnova Ventures Inc
Solasta Ventures
venBio Partners LLC
AXONIS Therapeutics Valuations & Financials
View real-time NPM data on AXONIS Therapeutics stock including daily AXONIS Therapeutics stock price estimates, valuation history, and historical share price information. Access AXONIS Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track AXONIS Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on AXONIS Therapeutics? Get in touch to learn more.
Similar Companies
like AXONIS Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Candor
Enterprise Software
Streamlines and optimizes stock-based compensation programs for public companies, enhancing management, compliance, and transparency.
Lendis
Provides flexible rental and management of office furniture and IT equipment, offering full-service solutions for modern workplace needs.
Bonus Homes
FinTech
Unlocking equity that lets homeowners access cash today while sharing in their home’s future growth without a typical sale.
Buk
Automates administrative tasks, enhances talent development, and facilitates employee access to benefits.
JenaValve Technology
Healthcare & Life Sciences
Bringing clip-anchored transcatheter valves to non-calcified aortic regurgitation with precise, minimally invasive implantation.
Productiv
Delivers deep SaaS application engagement analytics to help IT leaders optimize software investments and usage across the enterprise.
Two Six Technologies
Industrials
Building next-gen cyber, sensor, and mission analytics tools that deliver secure, real-time clarity to national security operations.
ianacare
Organizes caregiver tasks, mobilizes help from support networks, and connects users with resources and guidance.
FAQ
We have answers
AXONIS Therapeutics stock does not trade on public stock exchanges. AXONIS Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in AXONIS Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
AXONIS Therapeutics Stock does not trade on public stock exchanges. In order to sell AXONIS Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
AXONIS Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view AXONIS Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for AXONIS Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell AXONIS Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in AXONIS Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
AXONIS Therapeutics is a private company and has not had an IPO. There is currently no AXONIS Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to AXONIS Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
